Celgene deal

Sybron Chemicals Inc., a specialty chemical company, received an exclusive license to CELG's biotreatment technology, which uses microbes to degrade toxic waste streams. CELG will receive royalties. CELG will take a charge in the second quarter of $930,000, $500,000 of which represents a non-cash write down of fixed assets related to capital equipment, and the balance relating to severance. ...